October 2016 - Bioscience Americas

October 2016

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, and potentially, other cell types. For years, it has been clear that MSCs are a leading type of stem cell being investigated for therapeutic applications, because they have the potential to treat a wide range of acute and degenerative diseases. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that [...]

Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing

Bioscience Americas Senior Scientific Advisor Dr. Leslie Miller participated as a recognized expert in the field of stem cell biology at a major U.S. Food and Drug Administration (FDA) public hearing held recently at the National Institutes of Health in Bethesda, Maryland. The public hearing, attended in-person and on-line by more than 1,000 stem cell researchers and medical professionals, addressed the issue of FDA regulation of human cells, tissues, and cellular and tissue-based products and the FDA’s related draft Guidelines [...]

Bioscience Americas Sponsors Charitable Foundation

Bioscience Americas, LLC, a leading global developer of autologous stem cell treatment centers announced today the creation of a 501 (c) (3) qualified not-for-profit charitable entity to be called Solutions for a Healthier World Foundation, Inc. According to Bioscience Americas CEO Eric Stoffers, the Foundation’s mission will be to provide stem cell treatments to patients suffering from autoimmune diseases who are unable to afford the cost of Bioscience Americas innovative therapies. “As we advance our efforts to develop stem cell wellness [...]